Hot Trials Hot Trials 2021 The best critical care trials published in 2021 COVID-19 Dexamethasone The COVID STEROID 2 Trial Group. Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe HypoxemiaThe COVID STEROID 2 Randomized Trial. JAMA 2021;epublished October 21st Granholm. Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial. Intensive Care Med 2021;epublished November 10th The RECOVERY...

Hot Trials Hot Trials 2022 The best critical care trials published in 2022 twitter vimeo instagram social This email address is being protected from spambots. You need JavaScript enabled to view it. Other Years:   2021 | 2023 COVID-19 Writing Committee for the REMAP-CAP Investigators. Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial. JAMA 2022;epublished December 16th Frat. Effect of High-Flow Nasal Cannula Oxygen vs Standard Oxygen Therapy on Mortality in...